747 related articles for article (PubMed ID: 31358387)
1. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
[TBL] [Abstract][Full Text] [Related]
2. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
[TBL] [Abstract][Full Text] [Related]
3. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
4. No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.
Chew EY; Klein ML; Clemons TE; Agrón E; Ratnapriya R; Edwards AO; Fritsche LG; Swaroop A; Abecasis GR;
Ophthalmology; 2014 Nov; 121(11):2173-80. PubMed ID: 24974817
[TBL] [Abstract][Full Text] [Related]
5. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
6. A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.
van Asten F; Simmons M; Singhal A; Keenan TD; Ratnapriya R; Agrón E; Clemons TE; Swaroop A; Lu Z; Chew EY;
Ophthalmology; 2018 Apr; 125(4):559-568. PubMed ID: 29096998
[TBL] [Abstract][Full Text] [Related]
7. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
Awh CC; Lane AM; Hawken S; Zanke B; Kim IK
Ophthalmology; 2013 Nov; 120(11):2317-23. PubMed ID: 23972322
[TBL] [Abstract][Full Text] [Related]
8. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2023 Sep; 9(9):CD000254. PubMed ID: 37702300
[TBL] [Abstract][Full Text] [Related]
10. Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.
; Papudesu C; Clemons TE; Agrón E; Chew EY
Ophthalmology; 2018 Apr; 125(4):512-521. PubMed ID: 29153456
[TBL] [Abstract][Full Text] [Related]
11. Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.
Agrón E; Mares J; Clemons TE; Swaroop A; Chew EY; Keenan TDL;
Ophthalmology; 2021 Mar; 128(3):425-442. PubMed ID: 32858063
[TBL] [Abstract][Full Text] [Related]
12. Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations.
Wang JJ; Buitendijk GH; Rochtchina E; Lee KE; Klein BE; van Duijn CM; Flood VM; Meuer SM; Attia J; Myers C; Holliday EG; Tan AG; Smith WT; Iyengar SK; de Jong PT; Hofman A; Vingerling JR; Mitchell P; Klein R; Klaver CC
Ophthalmology; 2014 Mar; 121(3):667-75. PubMed ID: 24290803
[TBL] [Abstract][Full Text] [Related]
13. Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study.
Awh CC; Hawken S; Zanke BW
Ophthalmology; 2015 Jan; 122(1):162-9. PubMed ID: 25200399
[TBL] [Abstract][Full Text] [Related]
14. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
[TBL] [Abstract][Full Text] [Related]
15. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort.
Joachim N; Mitchell P; Rochtchina E; Tan AG; Wang JJ
Ophthalmology; 2014 Apr; 121(4):917-25. PubMed ID: 24332537
[TBL] [Abstract][Full Text] [Related]
16. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.
Yu JJ; Agrón E; Clemons TE; Domalpally A; van Asten F; Keenan TD; Cukras C; Chew EY;
Ophthalmology; 2019 Feb; 126(2):261-273. PubMed ID: 30142373
[TBL] [Abstract][Full Text] [Related]
17. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration.
Klein ML; Francis PJ; Rosner B; Reynolds R; Hamon SC; Schultz DW; Ott J; Seddon JM
Ophthalmology; 2008 Jun; 115(6):1019-25. PubMed ID: 18423869
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.
Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY
Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345
[TBL] [Abstract][Full Text] [Related]
19. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.
Aronow ME; Chew EY
Curr Opin Ophthalmol; 2014 May; 25(3):186-90. PubMed ID: 24614146
[TBL] [Abstract][Full Text] [Related]
20. The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.
Al-Holou SN; Tucker WR; Agrón E; Clemons TE; Cukras C; Ferris FL; Chew EY;
Ophthalmology; 2015 Dec; 122(12):2490-6. PubMed ID: 26435335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
